Global Blood Glucose Monitoring Equipment Market Growth 2025-2031
Description
The global Blood Glucose Monitoring Equipment market size is predicted to grow from US$ 6154 million in 2025 to US$ 10218 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A blood glucose monitoring equipment refers to an instrument used to measure blood sugar (glucose) levels in the human body. They are mainly divided into two categories: traditional fingertip blood glucose meter (including blood glucose meter and test strips) and continuous blood glucose monitoring system (CGM). Diabetics often use these devices to monitor blood sugar levels in order to adjust diet, exercise, and medication regimens.
Diabetes is a systemic disease caused by the interaction of genetic and environmental factors, resulting in insufficient insulin secretion, defective insulin action, or the simultaneous existence of both. "Three more and one less", that is, the clinical manifestations of "drinking more, urinating more, eating more and losing weight", are more common in type I diabetes, and patients with type I diabetes need lifelong insulin treatment; fatigue, weakness and obesity are more common in type II diabetes, and intensive insulin treatment has better therapeutic effects on patients with type II diabetes who have severely insufficient insulin secretion. The latest blood sugar is the only criterion for diagnosing diabetes. The World Health Organization's diagnostic criteria for diabetes are: fasting (no calories for at least 8 hours) blood sugar level ≥7 mmol/L, or diabetes symptoms + plasma glucose level ≥11.1 mmol/L at any time. my country is a high-incidence area of diabetes, and 141 million diabetic patients have released strong demand for blood sugar monitoring. As patient needs evolve, the importance of CGM is becoming increasingly prominent. There is a lot of room for improvement in the domestic CGM market penetration rate and domestic production rate.
LP Information, Inc. (LPI) ' newest research report, the “Blood Glucose Monitoring Equipment Industry Forecast” looks at past sales and reviews total world Blood Glucose Monitoring Equipment sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Glucose Monitoring Equipment sales for 2025 through 2031. With Blood Glucose Monitoring Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Glucose Monitoring Equipment industry.
This Insight Report provides a comprehensive analysis of the global Blood Glucose Monitoring Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Glucose Monitoring Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Glucose Monitoring Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Glucose Monitoring Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Glucose Monitoring Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Glucose Monitoring Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wearable
Not Wearable
Segmentation by Application:
Hospital Use
Home Use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
DexCom
Cnoga Medical
Medtronic
Senseonics Holdings
Glucotrack, Inc.
Medtrum Technologies
I-SENS
Roche
Ascensia
ARKRAY
OMRON
B. Braun Medical
AgaMatrix
ALL Medicus
Terumo Corporation
Sinocare
Huzhou Meiqi Medical Instruments
Zhejiang POCTech Corporation
MicroTech Medical
SIBIONICS
Bobang Fangzhou Medical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood Glucose Monitoring Equipment market?
What factors are driving Blood Glucose Monitoring Equipment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Glucose Monitoring Equipment market opportunities vary by end market size?
How does Blood Glucose Monitoring Equipment break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A blood glucose monitoring equipment refers to an instrument used to measure blood sugar (glucose) levels in the human body. They are mainly divided into two categories: traditional fingertip blood glucose meter (including blood glucose meter and test strips) and continuous blood glucose monitoring system (CGM). Diabetics often use these devices to monitor blood sugar levels in order to adjust diet, exercise, and medication regimens.
Diabetes is a systemic disease caused by the interaction of genetic and environmental factors, resulting in insufficient insulin secretion, defective insulin action, or the simultaneous existence of both. "Three more and one less", that is, the clinical manifestations of "drinking more, urinating more, eating more and losing weight", are more common in type I diabetes, and patients with type I diabetes need lifelong insulin treatment; fatigue, weakness and obesity are more common in type II diabetes, and intensive insulin treatment has better therapeutic effects on patients with type II diabetes who have severely insufficient insulin secretion. The latest blood sugar is the only criterion for diagnosing diabetes. The World Health Organization's diagnostic criteria for diabetes are: fasting (no calories for at least 8 hours) blood sugar level ≥7 mmol/L, or diabetes symptoms + plasma glucose level ≥11.1 mmol/L at any time. my country is a high-incidence area of diabetes, and 141 million diabetic patients have released strong demand for blood sugar monitoring. As patient needs evolve, the importance of CGM is becoming increasingly prominent. There is a lot of room for improvement in the domestic CGM market penetration rate and domestic production rate.
LP Information, Inc. (LPI) ' newest research report, the “Blood Glucose Monitoring Equipment Industry Forecast” looks at past sales and reviews total world Blood Glucose Monitoring Equipment sales in 2024, providing a comprehensive analysis by region and market sector of projected Blood Glucose Monitoring Equipment sales for 2025 through 2031. With Blood Glucose Monitoring Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Glucose Monitoring Equipment industry.
This Insight Report provides a comprehensive analysis of the global Blood Glucose Monitoring Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Glucose Monitoring Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Glucose Monitoring Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Glucose Monitoring Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Glucose Monitoring Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Glucose Monitoring Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wearable
Not Wearable
Segmentation by Application:
Hospital Use
Home Use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
DexCom
Cnoga Medical
Medtronic
Senseonics Holdings
Glucotrack, Inc.
Medtrum Technologies
I-SENS
Roche
Ascensia
ARKRAY
OMRON
B. Braun Medical
AgaMatrix
ALL Medicus
Terumo Corporation
Sinocare
Huzhou Meiqi Medical Instruments
Zhejiang POCTech Corporation
MicroTech Medical
SIBIONICS
Bobang Fangzhou Medical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood Glucose Monitoring Equipment market?
What factors are driving Blood Glucose Monitoring Equipment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Glucose Monitoring Equipment market opportunities vary by end market size?
How does Blood Glucose Monitoring Equipment break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
161 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Blood Glucose Monitoring Equipment by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Blood Glucose Monitoring Equipment by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
